Gil Redelman‐Sidi

3.4k citations
26 papers · 1.9k indexed · 1 hit paper · h-index 17

Gil Redelman‐Sidi

25 papers receiving 1.9k citations

Hit Papers

The mechanism of action of BCG therapy for bladder cancer...20142026201820222014100200300400500

Peers

Gil Redelman‐Sidi
Comparison fields: 5 of 98
  • Oncology 606
  • Immunology 581
  • Epidemiology 558
  • Surgery 527
  • Infectious Diseases 440
Replace P Piccoli with:
P Piccoli Italy
Christa S. Zerbe United States
Lisbet Sviland Norway
Ming Guo United States
Nicolas Mach Switzerland
David K. Hong United States
Hirofumi Teshima Japan
Françoise Carnot France
Cheng‐Lung Ku Taiwan
R Powles United Kingdom
Gil Redelman‐Sidi relative to P Piccoli Italy P Piccoli's profile →
Citations per field
00.5×3.8×
P Piccoli · 1×
Citations per year

Countries citing papers authored by Gil Redelman‐Sidi

Since Specialization
Citations

This map shows the geographic impact of Gil Redelman‐Sidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Redelman‐Sidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Redelman‐Sidi more than expected).

Fields of papers citing papers by Gil Redelman‐Sidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Redelman‐Sidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Redelman‐Sidi. The network helps show where Gil Redelman‐Sidi may publish in the future.

Co-authorship network of co-authors of Gil Redelman‐Sidi

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Redelman‐Sidi. A scholar is included among the top collaborators of Gil Redelman‐Sidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Redelman‐Sidi. Gil Redelman‐Sidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 68
3 8
4 60
5 2
6 70
7 74
8 5
9 78
10 87
11 58
12 226
13
The mechanism of action of BCG therapy for bladder cancer—a current perspectivebreakdown →
522
14 80
15 68
16 15
17 67
18 14
19 86
20
Pandemic H1N1 Influenza Infection in Cancer Patients
3

About Gil Redelman‐Sidi

Gil Redelman‐Sidi is a scholar working on Microbiology, Infectious Diseases and Oncology, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immune responses and vaccinations (5 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Microbiology (27 citations), Immunology (581 citations) and Infectious Diseases (440 citations). Gil Redelman‐Sidi has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Michael S. Glickman, Bernard H. Bochner, Kent A. Sepkowitz, Tobias M. Hohl, María del Carmen López Castillo, Michael A. Postow, Chrisann Kyi, Fabián Andrés Rosas Romero, Song Jiang and Susan K. Seo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026